Won-Tae Cha
Patrimonio netto: 18 M $ in data 31/08/2026
Patrimonio netto: 18 M $ in data 31/08/2026
Won-Tae Cha currently works at Cha Biotech Co., Ltd., as Chief Executive Officer from 2026, Cha Medical & Bio Group, as Vice Chairman, and Stem Cell & Regenerative Medicine International, Inc., as Director.
Mr. Cha received his undergraduate degree from Duke University, Masters Business Admin degree from Massachusetts Institute of Technology, graduate degree from Yale University, and doctorate degree from Yonsei University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 09/09/2026 | 3.110.518 ( 3,34% ) | 18 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CHABIOTECH CO.,LTD. | Amministratore Delegato | 04/03/2026 |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cha Biotech Co., Ltd.
Cha Biotech Co., Ltd. Electronic ComponentsElectronic Technology Manufactures and designs optical, digital, and medical products and related cell therapy and biological products | Electronic Technology |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale